Inactive Instrument

LA JOLL Stock Nasdaq

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

11/09/15	La Jolla : Pharmaceutical Company : Receives Positive Opinion from European Orphan Committee for LJPC-401	BU
10/09/15	La Jolla : Pharmaceutical Company : Announces Pricing of Underwritten Offering of Common Stock	BU
09/09/15	La Jolla : Pharmaceutical Company : Announces Proposed Underwritten Offering of Common Stock	BU
18/08/15	La Jolla : Pharmaceutical Company : Receives Orphan Drug Designation for Two Novel Compounds for Fibrodysplasia Ossificans Progressiva	BU
18/08/15	La Jolla : Pharmaceutical Company : and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors	BU

Employees

Sector